Filed Sep 3, 2026Period of report Sep 3, 20260001669639-26-000004
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Brian Michael BonnellChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Sep 1, 2026Period of report Sep 1, 20260001804831-26-000006
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Brian Michael BonnellChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Aug 31, 2026Period of report Aug 31, 20260001804831-26-000005
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Daniel WoolsonVP, GM-Infusion Capital
4
Filed Aug 13, 2026Period of report Aug 13, 20260001698998-26-000004
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 13, 2026
Common StockF1
5,417
$181.33
$982.26K
17,062
Direct
Ben SousaChief Information Officer
4
Filed Aug 12, 2026Period of report Aug 12, 20260002013412-26-000003
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 12, 2026
Common StockF1
2,250
$178.3152
$401.21K
3,076
Direct
Christian B. VoigtlanderChief Operating Officer
4
Filed Aug 11, 2026Period of report Aug 11, 20260001727477-26-000003
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 11, 2026
Common StockF1
8,929
$182.9325
$1.63M
37,377
Direct
Elisha W FinneyDirector
4
Filed Aug 11, 2026Period of report Aug 11, 20260001217439-26-000002
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 11, 2026
Common StockF1
378
$182.4818
$68.98K
4,871
Direct
Daniel WoolsonPresident
4
Filed May 22, 2026Period of report May 22, 20260001698998-26-000003
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 22, 2026
Common StockF1
2,123
$132.2114
$280.68K
22,479
Direct
Virginia Ruth SanzoneVP, General Counsel
4
Filed May 15, 2026Period of report May 14, 20260001669639-26-000003
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 14, 2026
Common StockF1
2,447
$124.08
$303.62K
19,460
Direct
David C. GreenbergDirector
4
Filed May 13, 2026Period of report May 13, 20260001645866-26-000001
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 12, 2026
Common StockF1
2,424
$122.91
$297.93K
7,960
Direct
Daniel WoolsonVP, GM-Infusion Capital
4
Filed Nov 25, 2025Period of report Nov 25, 20250001698998-25-000004
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 25, 2025
Common StockF1
2,897
$152.3522
$441.36K
11,297
Direct
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.
Sep 3, 2026
Common StockF1F2
2,202
$167.667
$369.20K
17,258
Direct
SaleSep 3, 2026
Common StockF1F3
1,238
$168.4352
$208.52K
16,020
Direct
SaleSep 3, 2026
Common StockF1F4
724
$169.5255
$122.74K
15,296
Direct
SaleSep 3, 2026
Common StockF1F5
692
$171.515
$118.69K
14,604
Direct
Filing footnotes · 5
F1The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.20 to $168.145, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.21 to $169.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.5 to $169.665, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.775 to $171.69, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F1The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026.
F2All shares sold were sold at the exact price disclosed.
F1The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.57 to $171.495, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.625 to $172.6, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.69 to $173.765, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.77 to $174.08, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.85 to $183.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.4808 to $182.5701, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.03 to $132.33, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.